Amoxapine Impurity 2 | CAS 3454-96-4 - Request Quote
Amoxapine Impurity 2
| SZ CAT No: | SZ-A048031 |
| CAS No | 3454-96-4 |
| Mol.F. | C18H18ClN3O |
| Mol.Wt. | 327.8 |
| Inv. Status | In Stock |
| Rel. CAT No | SZ-L100002 |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Amoxapine Impurity 2 is chemically 3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine. It is also known as Loxapine USP Related Compound A. Amoxapine Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Amoxapine Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Amoxapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3454-96-4
Purchase 3454-96-4
Order 3454-96-4
Enquire 3454-96-4
price of 3454-96-4
3454-96-4 Supplier
3454-96-4 Manufacturer
3454-96-4 Exporter
buy high quality Amoxapine Impurity 2
Purchase Amoxapine Impurity 2
Amoxapine Impurity 2 suppliers
Amoxapine Impurity 2 manufacturers
Amoxapine Impurity 2 price
Order Amoxapine Impurity 2
Enquire Amoxapine Impurity 2
Amoxapine Impurity 2 cost
Amoxapine Impurity 2 Supplier
Amoxapine Impurity 2 Distributor
Amoxapine Impurity 2 for Method Validation
Amoxapine Reference Standard
Amoxapine Impurity 2 for ANDA Filing
Amoxapine Impurity 2 for Forced Degradation Studies
Amoxapine Impurity 2 Identification Standards
Amoxapine Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.